PRODUCT LINE UP

Transcranial Magnetic Stimulation

SEE MORE

Pain Therapy

SEE MORE

Electrosurgical Unit

SEE MORE

Biosignal & Monitoring

SEE MORE

NEWS & EVENTS

Meet the latest information of REMED

[KIMES 2018 Clips] REMED Co.,Ltd. showing off a High-Tech Medical Device ´Transcranial Magnetic Stimulation´ by an Electromagnetic Field to treat Depression

April 20, 2018

REMED Co., Ltd participated in '34th Korea International Medical & Hospital Equipment Show (KIMES 2018)' at COEX from March 15 to 18 and showcased a transcranial magnetic stimulator and electromagnetic stimulator. REMED Co., Ltd is a research and production company of professional electronic medical devices. They developed a Transcranial Magnetic Stimulator(TMS) which is a high-tech medical device electromagnetic field. Also, they cover everything from R&D in medical devices related to rehabilitation therapy services, such as electromagnetic field therapy for musculoskeletal pain, extracorporeal shock wave therapy, and electrosurgical unit, to deliver and do clinics.   'ALTMS' (Transcranial Magnetic Stimulator) is a device that applies the electromagnetic field to the head for treatment of depression in adult patients. It is way more effective if the drugs are used at the same time. Even if only TMS is used to treat without medication, it has excellent therapeutic effects. It is effective if the drugs are ineffective or have side effects and also applicable to students and pregnant women who have trouble taking drugs.   On the other hand, KIMES is Korea's largest medical equipment and hospital facility exhibition which has grown steadily with the development of the Korean medical industry since its opening in 1980. The nation`s medical industry is now transformed into a technology-intensive high-tech industry, with medical information systems, ultrasound detectors and imaging medical devices, robotic medicine, AI and rehabilitation drugs. As KIMES contributes to the advancement of the Korean medical industry, it has become a world-class medical exhibition. At this exhibition, the participants will showcase new technologies and products from the medical industry, including high-tech hospital facilities, IT-enabled medical information systems, and the automotive industry for rapid patient transportation.   References:  http://us.aving.net/news/view.php?articleId=1384916 Video: ​ https:// www.youtube.com/watch?v=mSvBDKMSbSc#action=share ​  

VIEW DETAIL →
[NEWS] Townsville Hospital and Health Service - Queensland Australia

March 26, 2018

  For the first time in Queensland, Townsville patients with diabetic ulcers will receive electromagnetic stimulation treatment in a bid to drive down soaring rates of preventable amputations in North Queensland. The trial will test the technology on 50 patients using electromagnetic stimulation machines. The technique has previously been used successfully to decrease the healing times for people with surgical wounds, burns and other slow healing wounds but has never been used for people with diabetic foot ulcers. Diabetic foot ulcers form as a complication of diabetes and, if untreated and unmanaged, can lead to amputation in more than 90 per cent of cases. Townsville HHS head of podiatry Amy Langley said clinicians had received training on the new machines and have now begun the trial. “This is a really exciting clinical trial that has the potential to make a huge difference in the quality of lives for people with diabetic foot ulcers,” she said. “A foot ulcer occurs when an area of skin has broken down compromising underlying tissue. People with diabetes are prone to poor circulation which can result in poor healing and leave the area vulnerable to an ulcer developing. “Electromagnetic stimulation targets deep inside the wound and increases circulation in that area. Good circulation is a critical component to wound healing.” The equipment for the trial has been purchased through Queensland Health’s New Technology Funding Evaluation Program ($60,000) with the Townsville HHS pitching in $40,000 through its study, education and research trust. Data from the Australian Commission of Safety and Quality in Health Care has shown North Queensland regions have among the highest diabetes-related amputation rates in Australia. Outback Queensland (2), Cairns (6) and Townsville (10) feature in the top 10 regions in Australia for the highest hospital admissions for diabetes-related amputations per 100,000 people. Townsville Hospital diabetes and endocrinology staff specialist Associate Professor Usman Malabu said the electromagnetic stimulation study complemented a suite of major research into diabetes being conducted across the Townsville HHS. “Hospital admissions and amputations as a result of diabetic foot ulcers are disproportionately high in this region when compared with most of Australia,” he said. “This makes it vital that Townsville as the region’s major tertiary centre really leads the way in developing world-class treatment to drive down the number of people whose lives are getting adversely affected by diabetic foot ulcers.” Podiatrist and research coordinator Julie Goodall said the electronic stimulation machines provided a more intensive treatment than the shockwave therapy trial announced earlier in the year. “Shockwave therapy is used for wounds that without assistance would take months to heal and with this treatment we are hoping to reduce that to weeks,” Ms Goodall said. “The electromagnetic treatment is for much more complex and deeper wounds and we are hoping that it will reduce the time it takes to heal from years to months.” The Townsville HHS also continues to roll out a $500,000 diabetes telehealth trial funded by BUPA and the Australian Diabetes Society. This trial is using 3D digital cameras to track the improvement or deterioration of foot ulcers. Clinicians in regional areas can take a photo monitoring the length, width and depth of a foot ulcer and send it to a clinician in Townsville for review and reduces the needs for patients to travel to Townsville for a weekly or fortnightly appointment.      References:  https://www.facebook.com/townsvillehhs/posts/1550371844983073 ​  

VIEW DETAIL →

Check the Patents & Certificates of REMED

We are producing the best quality products.

SEE OUR PATENTS

REMED in Worldwide

CONTACT US

Get in touch with REMED

Contact Information

Address

#301~303, 187 Techno2-ro, Yuseong-gu, Daejeon 34025 Korea

E-mail

sales@remed.kr

Tel

+82-31-696-4886

Fax

+82-31-696-4877